217 related articles for article (PubMed ID: 17549313)
21. Laboratory detection of 'aspirin resistance': what test should we use (if any)?
Cattaneo M
Eur Heart J; 2007 Jul; 28(14):1673-5. PubMed ID: 17586540
[No Abstract] [Full Text] [Related]
22. Lack of biological relevance of platelet cyclooxygenase-2 dependent thromboxane A2 production.
Riondino S; Trifirò E; Principessa L; Mascioletti S; Di Renzo L; Gaudio C; Biasucci LM; Crea F; Pulcinelli FM
Thromb Res; 2008; 122(3):359-65. PubMed ID: 18295304
[TBL] [Abstract][Full Text] [Related]
23. New direct and indirect methods for the detection of cyclooxygenase 1 acetylation by aspirin; the lack of aspirin resistance among healthy individuals.
Kovács EG; Katona E; Bereczky Z; Homoródi N; Balogh L; Tóth E; Péterfy H; Kiss RG; Edes I; Muszbek L
Thromb Res; 2013 Apr; 131(4):320-4. PubMed ID: 23422285
[TBL] [Abstract][Full Text] [Related]
24. [Cyclooxigenase-1 gene polymorphism and aspirin resistance].
Bondar' TN; Kravchenko NA
Tsitol Genet; 2012; 46(4):66-72. PubMed ID: 23074965
[TBL] [Abstract][Full Text] [Related]
25. Letter by Violi et al regarding article, "Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization".
Violi F; Pignatelli P; Basili S
Circulation; 2010 Aug; 122(7):e429; author reply e430. PubMed ID: 20713906
[No Abstract] [Full Text] [Related]
26. Inhibition of platelet cyclooxygenase by aspirin-like drugs: methods for in vitro and ex vivo assessment.
Patrono C; Ciabattoni G; Pugliese F; Pinca E; Castrucci G; De Salvo A; Satta MA; Parachini M
Agents Actions Suppl; 1979; (4):138-46. PubMed ID: 115255
[No Abstract] [Full Text] [Related]
27. Study of inhibitors of the PGH synthases for which potency is regulated by the redox state of the enzymes.
Boutaud O; Oates JA
Methods Mol Biol; 2010; 644():67-90. PubMed ID: 20645166
[TBL] [Abstract][Full Text] [Related]
28. Protocatechualdehyde synergizes with aspirin at the platelet cyclooxygenase-1 level.
Sun S; Hao H; Gong P; Tang Z; Li F; Chen X; Shi H; Wang G
Planta Med; 2011 Nov; 77(17):1898-904. PubMed ID: 21728147
[TBL] [Abstract][Full Text] [Related]
29. De novo synthesis of cyclooxygenase-1 counteracts the suppression of platelet thromboxane biosynthesis by aspirin.
Evangelista V; Manarini S; Di Santo A; Capone ML; Ricciotti E; Di Francesco L; Tacconelli S; Sacchetti A; D'Angelo S; Scilimati A; Sciulli MG; Patrignani P
Circ Res; 2006 Mar; 98(5):593-5. PubMed ID: 16484611
[TBL] [Abstract][Full Text] [Related]
30. No case of COX-1-related aspirin resistance found in 289 patients with symptoms of stable CHD remitted for coronary angiography.
Meen O; Brosstad F; Khiabani H; Gjertsen E; Lauritsen ME; Pedersen TM; Bjørnsen S; Schjelderup NM; Ameln W; Ng EC; Wettergreen M; Siddique SP; Erikssen G
Scand J Clin Lab Invest; 2008; 68(3):185-91. PubMed ID: 17934975
[TBL] [Abstract][Full Text] [Related]
31. Aspirin resistance transient laboratory finding or important clinical entity?
Lev EI
J Am Coll Cardiol; 2009 Feb; 53(8):678-80. PubMed ID: 19232900
[No Abstract] [Full Text] [Related]
32. Triflusal vs aspirin on the inhibition of human platelet and vascular cyclooxygenase.
de la Cruz JP; Mata JM; Sanchez de la Cuesta F
Gen Pharmacol; 1992 Mar; 23(2):297-300. PubMed ID: 1639242
[TBL] [Abstract][Full Text] [Related]
33. Heritability of platelet responsiveness to aspirin in activation pathways directly and indirectly related to cyclooxygenase-1.
Faraday N; Yanek LR; Mathias R; Herrera-Galeano JE; Vaidya D; Moy TF; Fallin MD; Wilson AF; Bray PF; Becker LC; Becker DM
Circulation; 2007 May; 115(19):2490-6. PubMed ID: 17470694
[TBL] [Abstract][Full Text] [Related]
34. Theoretical investigation of aspirin dosage regimen to exhibit optimal antiplatelet effects and decrease risk of upper gastrointestinal lesions.
Yokoyama H; Yaguchi T; Suzuki Y; Tokuoka K; Watanabe M; Kitagawa Y; Yamada Y
Biol Pharm Bull; 2012; 35(12):2112-8. PubMed ID: 23047244
[TBL] [Abstract][Full Text] [Related]
35. Aspirin resistance: is this term meaningful?
Violi F; Pignatelli P
Curr Opin Hematol; 2006 Sep; 13(5):331-6. PubMed ID: 16888437
[TBL] [Abstract][Full Text] [Related]
36. Lack of aspirin-induced decrease in thrombin formation in subjects resistant to aspirin.
Undas A; Placzkiewicz-Jankowska E; Zieliński L; Tracz W
Thromb Haemost; 2007 Jun; 97(6):1056-8. PubMed ID: 17549314
[No Abstract] [Full Text] [Related]
37. [Mechanism of changes in the platelet functional activity caused by low energy laser irradiation].
Spasov AA; Nedogoda VV; Konan K
Biull Eksp Biol Med; 1998 Jul; 126(7):45-8. PubMed ID: 9777195
[No Abstract] [Full Text] [Related]
38. Nitrooxyacyl derivatives of salicylic acid: aspirin-like molecules that covalently inactivate cyclooxygenase-1.
Cena C; Tosco P; Marini E; Lazzarato L; Piccinini M; Ramondetti C; Lupino E; Fruttero R; Gasco A
ChemMedChem; 2011 Mar; 6(3):523-30. PubMed ID: 21360823
[TBL] [Abstract][Full Text] [Related]
39. Development of Poly Unsaturated Fatty Acid Derivatives of Aspirin for Inhibition of Platelet Function.
Roy J; Adili R; Kulmacz R; Holinstat M; Das A
J Pharmacol Exp Ther; 2016 Oct; 359(1):134-41. PubMed ID: 27488919
[TBL] [Abstract][Full Text] [Related]
40. Selectivity of oral aspirin as an inhibitor of platelet vs. vascular cyclooxygenase activity is reduced by portacaval shunt in rats.
Gambino MC; Passaghe S; Chen ZM; Bucchi F; Gori G; Latini R; de Gaetano G; Cerletti C
J Pharmacol Exp Ther; 1988 Apr; 245(1):287-90. PubMed ID: 3129553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
